The first four weeks cost around 129,800 won at supply price. Hanmi reports 9.75% average weight loss over 40 weeks and has set a 100 billion won first-year sales target.
Recap by typeshit. Full story at Businesskorea.
Miller credits a 25% drop in weight with yearly savings in healthcare spending per person and brings up retatrutide's results.
Prof Jeanne Lubbe and Discovery Health weigh in. Discovery says GLP-1 claims tripled from 2022 to 2025, with members claiming for 5.4 months on average.
A guide to employer plans, Medicare Part D's weight-loss exclusion, Medicaid and paying cash, plus how added uses like sleep apnea open coverage.
Employers on the Andel marketplace set their own contribution toward Wegovy, the daily Wegovy pill and Wegovy HD, with manufacturer-direct pricing and no insurance involved.
Health and Me ties the Australian actor and stuntman's death to peptides as RFK Jr. moves to loosen US rules on six unapproved peptides over FDA objections.
A short Instagram clip from @realdrbae on side effects he links to the GLOW blend. These are his claims, and the clip itself gives few details.
Loading…